Purchases and Sales Made in Q2 2024 in Neurocrine Biosciences Inc (NBIX)
This table provides information about the institutional ownership of Neurocrine Biosciences Inc (NBIX) during Q2 2024. The information is specifically focused on institutions that hold shares of NEUROCRINE BIOSCIENCES INC.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 14, 2024
Q2 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-141K- 56.13% |
$18.5M - $20.3M
|
111K
$15.8M
|
|
Aug 14, 2024
Q2 2024
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-155K- 19.21% |
$20.2M - $22.1M
|
650K
$93.1M
|
|
Aug 14, 2024
Q2 2024
|
Bellevue Group Ag
Kuesnacht, V8 |
SELL
|
- |
-157K- 7.65% |
$20.6M - $22.5M
|
1.9M
$272M
|
|
Aug 14, 2024
Q2 2024
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-161K- 82.19% |
$21M - $23M
|
34.8K
$4.98M
|
|
Aug 14, 2024
Q2 2024
|
Polar Capital Holdings PLC
London, X0 |
SELL
|
- |
-165K- 21.28% |
$21.6M - $23.6M
|
611K
$87.5M
|
|
Aug 12, 2024
Q2 2024
|
National Pension Service
Jeonju Si, Jeollabuk Do, M5 |
SELL
|
- |
-174K- 99.9% |
$22.8M - $24.9M
|
180
$25.8K
|
|
Aug 05, 2024
Q2 2024
|
Los Angeles Capital Management LLC
|
SELL
|
- |
-188K- 76.82% |
$24.7M - $27M
|
56.9K
$8.15M
|
|
Aug 13, 2024
Q2 2024
|
Pictet Asset Management Holding Sa
Carouge, V8 |
SELL
|
- |
-210K- 19.43% |
$27.5M - $30.1M
|
871K
$125M
|
|
Jul 29, 2024
Q2 2024
|
Panagora Asset Management Inc
Boston, MA |
SELL
|
- |
-260K- 97.14% |
$34M - $37.2M
|
7.65K
$1.1M
|
|
Aug 14, 2024
Q2 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-268K- 58.81% |
$35M - $38.3M
|
187K
$26.9M
|
|
Oct 07, 2024
Q2 2024
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
SELL
|
- |
-357K- 91.2% |
$46.7M - $51.1M
|
34.4K
$4.93M
|
|
Aug 14, 2024
Q2 2024
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
SELL
|
- |
-357K- 91.2% |
$46.7M - $51.1M
|
34.4K
$4.93M
|
|
Aug 14, 2024
Q2 2024
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-407K- 29.55% |
$53.3M - $58.3M
|
971K
$139M
|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-521K- 25.21% |
$68.1M - $74.6M
|
1.54M
$221M
|
|
Aug 14, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-521K- 25.21% |
$68.1M - $74.6M
|
1.54M
$221M
|